![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|11|25|3307-3315
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.11, Iss.25, 2005-10, pp. : 3307-3315
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New drug targets for resistant hypertension look promising
Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nitric Oxide and Cyclic GMP Signaling Pathway as a Focus for Drug Development
Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Upregulation of platelet L-arginine – nitric oxide pathway after exercise training in hypertension
By Matsuura Cristiane Brunini Tatiana M.C. Mury Wanda V. Garcia-Pinto Angelica B. Carvalho Jorge J. Mendes-Ribeiro Antonio Cláudio
Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 4, 2012-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Nitric Oxide Signaling Pathway in the Penis
Current Pharmaceutical Design, Vol. 11, Iss. 31, 2005-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhaled nitric oxide worth it for neonatal pulmonary hypertension
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 460, 2004-01 ,pp. :